BLK vs FENC · P/E 27, rev $24.22B vs rev $17.9M
BlackRock Inc (BLK) versus Fennec Pharmaceuticals Inc (FENC) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Laurence Douglas Fink.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. FENC currently screens at market cap $302.2M.
Not investment advice. Open the BLK and FENC stock pages for the full models.
Not investment advice.